LONDON, Nov 22 GSK will stop selling its blood cancer drug Blenrep in the United States, it said today, representing the latest in a series of setbacks for the British.
LONDON, June 1 US drugs giant Pfizer will exit its consumer healthcare joint venture with GlaxoSmithKline after the unit is spun off next month, the British drugmaker said.